H840 Oxonic acid potassium salt - AK Scientific
 
 
Loading Please Wait...
  Catalog ID # H840
formerly cat #H840
Oxonic acid potassium salt
, 98% (HPLC)
 
4,6-Dihydroxy-1,3,5-triazine-2-carboxylic acid potassium salt
Allantoxanic acid
Potassium oxonate




IDENTITY
CAS Registry #:[2207-75-2]
MDL Number:MFCD00010565
MF:C4H2KN3O4
MW:195.17
EINECS:218-627-5
BRN:4049961
SPECIFICATIONS & PROPERTIES
Purity:98% (HPLC)
Available Spectra:LCMS, HPLC
Physical Form:White to off-white powder
Melting Point:>300°C
Long-Term Storage:Store at room temperature
Shipping:Not Regulated for Shipping

REVIEW

 Oxonic acid potassium salt is a biochemical modulator in the tegafur/gimeracil/oxonic acid potassium salt combination anticancer drug, which is used for the treatment of advanced gastric cancer and hepatocellular carcinoma. Due to its low permeability, oxonic acid potassium salt stays in the gut, where it reduces the production of 5-fluorouracil by blocking the enzyme orotate phosphoribosyltransferase. Lower 5-fluorouracil levels in the gut result in a lower gastrointestinal toxicity. A similar approach is present in S-1-gimeracil and oteracil potassium used for the treatment of gastric cancer.

REFERENCES
[1]Piskala, A.; Gut, J. Nucleic acid components and their analogs. XX. Synthesis of oxonic acid (2,4-dioxo-1,2,3,4-tetrahydro-1,3,5-triazine-6-carboxylic acid) and the acetylation of 2,4-dioxohexahydro-1,3,5-triazines Collection of Czechoslovak Chemical Communications (1962), 27, 1562-71.
[2] Piskala, Alois; Gut, Jiri Potassium 1,2,3,4-tetrahydro-2,4-dioxo-s-triazine-6-carboxylate (potassium 5-aza-orotate). Cyclocondensation of biuret with ethyl potassium oxalate Edited by Townsend, Leroy B.; Tipson, R. Stuart , Nucleic Acid Chem. (1978), 1, 93-5.
[3] Sugi, Mitsuyo; Igi, Masami Preparation of potassium oxonate by oxidation of allantoin using alkali metal hypohalite. Eur. Pat. Appl. (1999), EP 957096 A1 19991117.
[4] Kobayakawa M, Kojima Y.Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies. Onco Targets Ther. 2011;4:193-201.

Risk Description(s)
R36/37/38:Irritating to eyes, respiratory system and skin

Safety Description(s)
S24/25:Avoid contact with skin and eyes.


Pricing (not showing? please refresh your web browser)

CURRENT AS OF: February 12, 2016

Availability
1. Backordered: Please contact us for availability.
2. All prices FOB San Francisco, USA

HazMat
HazMat shipping information is based on IATA/DOT regulations. All of the information is for reference only and subject to change without notice.
1. Not Required: Normal shipping for Ground and Express.
2. Required for Express: HazMat shipping via Express. Normal shipping for continental Ground.

Quality
1. All products' quality is guaranteed.
2. Lot-specific spectra and CoA available on request.

SDS

 H840_SDS.pdf

CATEGORIES

 APIs and Bioactives > Chemotherapeutics

USEFUL LINKS

  PubChem